Eastwood Bio-Medical Canada (TSXV:EBM) EBIT : C$-0.46 Mil (TTM As of Jul. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Eastwood Bio-Medical Canada EBIT?

Eastwood Bio-Medical Canada's earnings before interest and taxes (EBIT) for the three months ended in Jul. 2024 was C$-0.10 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jul. 2024 was C$-0.46 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Eastwood Bio-Medical Canada's annualized ROC % for the quarter that ended in Jul. 2024 was -117.61%. Eastwood Bio-Medical Canada's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jul. 2024 was -148.80%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Eastwood Bio-Medical Canada's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jul. 2024 was -0.96%.

Eastwood Bio-Medical Canada EBIT Historical Data

The historical data trend for Eastwood Bio-Medical Canada's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eastwood Bio-Medical Canada EBIT Chart

Eastwood Bio-Medical Canada Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

EBIT

Get a 7-Day Free Trial

-0.58

-0.85

-0.60

-0.14

-0.52

Eastwood Bio-Medical Canada Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
EBIT	Get a 7-Day Free Trial															-0.12	-0.17	-0.06	-0.13	-0.10

Competitive Comparison of Eastwood Bio-Medical Canada's EBIT

For the Food Distribution subindustry, Eastwood Bio-Medical Canada's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eastwood Bio-Medical Canada's EV-to-EBIT Distribution in the Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, Eastwood Bio-Medical Canada's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Eastwood Bio-Medical Canada's EV-to-EBIT falls into.

Eastwood Bio-Medical Canada EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.46 Mil.

Eastwood Bio-Medical Canada (TSXV:EBM) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Eastwood Bio-Medical Canada's annualized ROC % for the quarter that ended in Jul. 2024 is calculated as:

	ROC % (Q: Jul. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Apr. 2024 )	+	Invested Capital (Q: Jul. 2024 ))	/ count )
=	-0.404 * ( 1 - 0% )	/	( (0.335	+	0.352)	/ 2 )
=	-0.404	/	0.3435
=	-117.61 %

where

	Invested Capital		(Q: Apr. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.359	-	1.334	-	( 0.008	-	max(0, 1.384	-	0.074	+	0.008	))
=	0.335

	Invested Capital		(Q: Jul. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.331	-	1.378	-	( 0.013	-	max(0, 1.472	-	0.073	+	0.013	))
=	0.352

Note: The Operating Income data used here is four times the quarterly (Jul. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Eastwood Bio-Medical Canada's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jul. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jul. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Apr. 2024		Q: Jul. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.404	/	( ( (0.285 + max(-1.275, 0))	+	(0.258 + max(-1.347, 0)) )	/	2 )
=	-0.404	/	( ( 0.285	+	0.258 )	/	2 )
=	-0.404	/	0.2715
=	-148.80 %

where Working Capital is:

	Working Capital		(Q: Apr. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.034	+	0	+	0.032)	-	(1.334	+	0.008	+	-0.0010000000000001)
=	-1.275

	Working Capital		(Q: Jul. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.037	+	0	+	0.023)	-	(1.378	+	0.029	+	2.2204460492503E-16)
=	-1.347

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jul. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Eastwood Bio-Medical Canada's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jul. 2024 )
	=	-0.464	/	48.272
	=	-0.96 %

Eastwood Bio-Medical Canada EBIT Related Terms

Thank you for viewing the detailed overview of Eastwood Bio-Medical Canada's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Eastwood Bio-Medical Canada Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » Eastwood Bio-Medical Canada Inc (TSXV:EBM) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

4871 Shell Road, Suite 1130, Richmond, BC, CAN, V6X 3Z6

Website

https://www.eleotin.ca

Eastwood Bio-Medical Canada Inc is a Canadian company engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The company is engaged in natural health supplement distribution company. It has its geographic presence in U.S., Canada and Asia. The company generates maximum revenue from Asia.

Executives

Yunji Kim	Senior Officer
Youngsoo Kim	Director or Senior Officer of 10% Security Holder

Eastwood Bio-Medical Canada Headlines

No Headlines